In this disclosure, a method is described wherein the method comprises mixing a therapeutic gas or a therapeutic liquid or a combination thereof and a liquid carrier in a high shear device to produce a dispersion; and administering the produced dispersion intravenously to a patient; wherein the prod
In this disclosure, a method is described wherein the method comprises mixing a therapeutic gas or a therapeutic liquid or a combination thereof and a liquid carrier in a high shear device to produce a dispersion; and administering the produced dispersion intravenously to a patient; wherein the produced dispersion contains nanobubbles of the therapeutic gas or droplets of the therapeutic liquid with a mean diameter of less than about 1.5 μm. In this disclosure, a method is described wherein the method comprises mixing a therapeutic gas or a therapeutic liquid or a combination thereof and a liquid carrier in a high shear device to produce a therapeutic fluid, wherein said therapeutic fluid is a solution, a dispersion, or combination thereof and administering the produced therapeutic fluid intravenously to a patient; wherein the solution is supersaturated with the therapeutic gas, the therapeutic liquid, or combination thereof.
대표청구항▼
1. A method comprising mixing a therapeutic gas or a therapeutic liquid or a combination thereof and a liquid carrier in a high shear device to produce a therapeutic fluid, wherein said therapeutic fluid is a solution, a dispersion, or combination thereof containing the therapeutic gas, therapeutic
1. A method comprising mixing a therapeutic gas or a therapeutic liquid or a combination thereof and a liquid carrier in a high shear device to produce a therapeutic fluid, wherein said therapeutic fluid is a solution, a dispersion, or combination thereof containing the therapeutic gas, therapeutic liquid, or combination thereof in sub-nano size, and wherein the high shear device comprises at least one rotor and at least one complementarily-shaped stator; andadministering the produced therapeutic fluid intravenously to a patient;wherein the therapeutic fluid is supersaturated with the therapeutic gas, the therapeutic liquid, or combination thereof. 2. The method of claim 1 wherein said therapeutic fluid is no less than 5% supersaturated. 3. The method of claim 1 wherein said therapeutic gas is selected from the group consisting of ozone, sulfur based gases, carbon monoxide, oxygen, hydrogen, nitrogen, an anesthetic gas, a noble gas, and mixtures thereof. 4. The method of claim 1 wherein said therapeutic liquid is selected from the group consisting of sulfur, a sulfate, an organo metallic, an antibiotic, a steroid, a vitamin, an organosulfur compound, allyl propyl disulfide, diallyl disulfide (DADS or 4,5-dithia-1,7-octadiene), allyl trisulfide (DATS), S-Allyl cysteine (SAC), a vinyldithiine, a sulfonyl compound, an antioxidant, a lipid, a chelating agent, and combinations thereof. 5. The method of claim 4 wherein said antioxidant comprises curcumin (turmeric); wherein said chelating agent comprises diethylene triamine pentaacetic acid (DTPA); wherein said vinyldithiine comprises 2-vinyl-[4H]-1,3-dithiine or 3-vinyl-[4H]-1,2-dithiine; wherein said organosulfur compound comprises allicin; and wherein said sulfonyl compound comprises ajoene. 6. The method of claim 1 wherein the therapeutic gas comprises hydrogen or hydrogen sulfide or oxygen. 7. The method of claim 1 wherein the therapeutic gas is oxygen and the produced therapeutic fluid is utilized in conjunction with a blood substitute. 8. The method of claim 1 wherein a combination of therapeutic gases or a combination of therapeutic liquids or a combination of therapeutic gas and liquid is utilized. 9. The method of claim 1 wherein said liquid carrier comprises a total parenteral nutrition (TPN) solution. 10. The method of claim 1 wherein said liquid carrier comprises an enhancer for carrying said therapeutic gas or said therapeutic liquid. 11. The method of claim 1 further comprising incorporating a medicine into the produced therapeutic fluid prior to administering the therapeutic fluid to the patient.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (8)
Langer, Deborah A.; Westfall, David L.; Skoch, William E.; Mullay, John J., Continuous process for making an aqueous hydrocarbon fuel.
Deborah A. Langer ; David L. Westfall ; Morris E. Smith ; Robert T. Graf ; Harshida Dave ; John J. Mullay ; Daniel T. Daly ; Elizabeth A. Schiferl, Process and apparatus for making aqueous hydrocarbon fuel compositions, and aqueous hydrocarbon fuel composition.
Deborah A. Langer ; David L. Westfall ; Morris E. Smith ; Robert T. Graf ; Harshida Dave ; John J. Mullay ; Daniel T. Daly ; Elizabeth A. Schiferl ; Brian B. Filippini ; William D. Abraham, Process and apparatus for making aqueous hydrocarbon fuel compositions, and aqueous hydrocarbon fuel composition.
Deborah A. Langer ; David L. Westfall ; Morris E. Smith ; Robert T. Graf ; Harshida Dave ; John J. Mullay ; Daniel T. Daly ; Elizabeth A. Schiferl ; Brian B. Filippini ; William D. Abraham , Process and apparatus for making aqueous hydrocarbon fuel compositions, and aqueous hydrocarbon fuel compositions.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.